Calcium Phosphate Coating on Ti6Al4V Using Lactate Buffer
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for coating titanium alloy (Ti6Al4V) implants with calcium phosphate (CaP) using simulated body fluids often require buffering agents like Tris/HCl, which increase chloride ion concentrations beyond those in human blood plasma, affecting the coating's adhesion and integration with bone tissue.
Innovation Solution
A new biomimetic solution, Lac-SBF, is developed using sodium lactate and lactic acid to maintain physiological pH without Tris/HCl, combined with chemical etching using NaOH+H2O2 and heat treatment, to create a CaP coating that matches human blood plasma ion concentrations, enhancing adhesion strength.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If Tris/HCl buffer is used in simulated body fluid for CaP coating, then pH control is achieved, but chloride ion concentration increases beyond human blood plasma levels, affecting coating adhesion and bone integration
Solution Approach 1:
The patent changes the buffer system parameters by replacing Tris/HCl with a NaHCO3/H2CO3 buffer system that maintains physiological pH (7.4) while matching human blood plasma chloride ion concentration (103 mM). This parameter change resolves the contradiction by achieving pH control without excessive chloride ions, enabling proper coating adhesion and bone integration
Solution Approach 2:
The patent creates a more accurate copy of human blood plasma by using a buffer system and ion composition that closely mimics physiological conditions. The Lac-SBF solution copies the chloride ion concentration (103 mM) and pH (7.4) of human blood plasma, eliminating the harmful deviation caused by Tris/HCl buffers
2Strength
If Ti6Al4V substrates are used for orthopedic implants, then mechanical properties and corrosion resistance are achieved, but osseointegration with surrounding hard tissue is prevented
Solution Approach 1:
The patent applies preliminary chemical etching using NaOH and NaOH+H2O2 treatments, followed by heat treatment at 600°C for 1 hour, to create a surface morphology that promotes osteoblast adhesion. This preliminary surface preparation enables subsequent CaP coating to integrate with bone tissue, resolving the lack of biological interaction while maintaining the inherent strength and corrosion resistance of Ti6Al4V
Solution Approach 2:
The patent creates a composite structure by depositing calcium phosphate coating on the Ti6Al4V substrate. This composite material combines the mechanical strength and corrosion resistance of titanium alloy with the bioactivity of CaP, enabling both structural integrity and osseointegration with surrounding hard tissue
3Strength
If CaP coating is applied to enhance bone integration, then adhesion strength increases, but coating process complexity increases due to multiple treatment steps
Solution Approach 1:
The patent merges the buffering function into the simulated body fluid composition itself by using NaHCO3/H2CO3 as the buffer system, eliminating the need for separate Tris/HCl buffer additions. This merging of functions simplifies the overall coating process while maintaining the necessary pH control and chloride ion concentration for optimal CaP coating adhesion strength
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Lac-SBF solution improves the adhesion strength of CaP coatings on Ti6Al4V substrates, leading to stronger bonding with bone tissue and quicker integration, as demonstrated by increased pull-out forces in biomechanical tests, thereby reducing patient recovery time.
Implementation Method 1
the substrates were chemically treated in NaOH and NaOH+H 2 O 2 as an alternative route
Implementation Method 2
heat treated at 600°C for 1 hour in air
Implementation Method 3
heat treated at 600°C for 1 hour in air
Implementation Method 4
a new solution was developed to coat CaP on Ti6Al4V alloy substrates... The inorganic ion concentrations of the Lac-SBF solutions were identical with those of human blood plasma
Data Source
Figure 1
Figure 2
Figure 3(a)~3(b)
AI summary
The invention related to a modified biomimetic coating method of Calcium Phosphate (CaP) based material on Ti6Al4V surfaces of implants is a method, wherein, in which prior to process, the substrate material to be coated is chemically treated in NaOH+H.sub.2O.sub.2, then a synthesis of CaP based (bioceramic) coating is performed using the biomimetic growth in Simulated Body Fluid (SBF) contains appropriate amounts of sodium lactate (NaL) and lactic acid (HL).